The effect of high glucose on SERT, the human plasmalemmal serotonin transporter

Nutritional Neuroscience

Volumn 11, Issue 6, 2008, Pages 244-250

  Gonçalves, Pedro ^a   Araújo, João R ^a   Martel, Fátima ^a  

^a University of Porto   (Portugal)

Author keywords

Caco 2 cells; Glucose; Plasmalemmal serotonin transporter; SERT

Indexed keywords

DESIPRAMINE; FLUOXETINE; GLUCOSE; NORADRENALIN; SEROTONIN; SEROTONIN TRANSPORTER;

ARTICLE; BINDING AFFINITY; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SEROTONIN UPTAKE;

CACO-2 CELLS; GLUCARIC ACID; HUMANS; KINETICS; NOREPINEPHRINE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TIME FACTORS; TRITIUM;

EID: 56349124702     PISSN: 1028415X     EISSN: 14768305     Source Type: Journal    
DOI: 10.1179/147683008X344156     Document Type: Article

References (38)

1. Blakely RD, Berson HE, Fremeau RT et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature 1991; 354: 66-70.
2. Uoffman B, Mezey E, Brownstein M. Cloning of a serotonin transporter affected by antidepressants. Science 1991; 254: 579-580.
3. Chang AS, Chang SM, Starnes DM, Schroeter S, Bauman AL, Blakely RD. Cloning and expression of the mouse serotonin transporter. Mol Brain Res 1996; 43: 185-192.
4. Mortensen OV, Kristensen AS, Rudnick G, Wiborg O. Molecular cloning, expression and characterization of a bovine serotonin transporter. Brain Res Mol Brain Res 1999; 71: 120-126.
5. Ramamoorthy S, Bauman AL, Moore KR et al. Antidepressant and cocaine-sensitive human serotonin transporter: molecular cloning, expression and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 2542-2546.
6. Blakely RD, De Felice LJ, Hartzell HC. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994; 196: 263-281.
7. Gainetdinov RR, Caron MG. Monoamine transporters: from genes to behavior. Annu Rev Pharmacal Toxicol 2003: 43: 261-284.
8. Iversen L. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol 2006; 147 (Suppl 1): S82-S88.
9. Coates MD, Mahoney CR, Linden DR et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 26: 1657-1664.
10. Mokrovic G, Matosic A, Hranilovic D et al. Alcohol dependence and polymorphisms of serotonin-related genes: association studies. Coll Antropol 2008; 32 (Suppi 1): 127-131.
11. Katsuyama H, Tomita M, Hidaka K et al. Association between serotonin transporter gene polymorphisms and depressed mood caused by job stress in Japanese workers. Int J Mol Med 2008; 21: 499-505.
12. Zaboli G, Jönsson EG, Gizatullin R, De Franciscis A, Asberg M, Leopardi R. Haplotype analysis confirms association of the serotonin transporter (5-HT) gene with schizophrenia but not with major depression. Am J Med Genet B Neurosychiatr Genet 2008; 147: 301-307.
13. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, Diabetes Care 1998; 21: 1414-1431.
14. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047-1053.
15. Sesti G. Pathophysiology of invulin resistance. Best Pract Res Clin Endocrinol Metab 2006; 20: 665-679.
16. Thomson AB, Wild G. Adaptation of intestinal nutrient transport in health and disease. Part II. Dig Dis Sci 1997; 42: 470-488.
17. Contreras R, Fuentes O, Mann GE, Sobrevia L. Diabetes and insulin-induced stimulation of L-arginine transport and nitric oxide synthesis in rabbit isolated gastric glands. J Physiol 1997; 498: 787-796.
18. Casirola DM, Vinnakota RR, Ferraris RP. Intestinal amino acid transport in mice is modulated by diabetes and diet. J Nutr 1994; 124: 842-852.
19. Adibi SA. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am J Physiol 2003; 285: G779-G788.
20. Carratu R, Secondulfo M, de Magistris L et al. Altered intestinal permeability to mannitol in diabetes mellitus type I. J Pediatr Gastroenterol Nutr 1999; 28: 264-269.
21. Basu TK, Basualdo C. Vitamin A homeostasis and diabetes mellitus. Nutrition 1997; 13:804-806.
22. Schedl HP, Christensen KK, Ronnenberg WC. Effects of diabetes on calcium uptake by rat brush border membrane vesicles. Clin Exp Pharmacol Physiol 1995; 22: 272-276.
23. Naggar H, Ola MS, Moore P et al. Downregulation of reduced-folate transporter by glucose in cultured RPE cells and in RPE of diabetic mice. Invest Ophthalmol Vis Sci 2002; 43: 556-563.
24. Faria A, Monteiro R, Azevedo I, Calhau C. Extracellular glucose concentration alters hEMT expression in Caco-2 cells. Acta Biomed 2006; 77 (Suppl 3): 62
25. Delie F, Rubas W. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of tile Caco-2 model. Crit Rev Ther Drug Carr Syst 1997; 14: 221-286.
26. Martel F, Monteiro R, Lemos C. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J Pharmacol Exp Ther 2003; 306: 355-362.
27. Bradford MM. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976: 72: 248-254.
28. Motulsky HJ, Spannard P, Neubig R. Graphpad Prism, version 1.0. San Diego, CA: Graphpad Prism Software, 1994.
29. Unal R, Ahmed BA, Jeffus BC et al. At diabetes-like concentration, glucose down-regulates the placental serotonin transport system in a cell-cycle-dependent manner. J Neurochem 2007; 101: 937-948.
30. Martel F, Gonçalves P, Azevedo I. Absorption of folate by Caco-2 cells is not affected by high glucose concentration. Eur J Pharmacol 2006; 551:19-26.
31. Jacob RJ, Fan X, Evans ML, Dziura J, Sherwin RS. Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: no evidence for protective adaptation by the blood brain barrier. Metabolism 2002; 51: 1522-1524.
32. Gregg EW, Yaffe K, Cauley JA et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 2000; 160: 174-180.
33. Padbury JF, Tseng YT, McGonnigal B, Penado K, Stephan M, Rudnick G. Placental biogenic amine transporters: cloning and expression. Brain Res Mol Brain Res 1997;45: 163-168.
34. Nguyen TT, Tseng YT, McGonnigal B et al. Placental biogenic amine transporters: in vivo function, regulation and pathobiological significance. Placenta 1999: 20: 3-11.
35. Ganapathy V, Prasad PD, Ganapathy ME, Leibach FH. Placental transporters relevant to drug distribution across the maternal-fetal interface. J Pharmacol Exp Ther 2000; 294: 413-420.
36. Ganapathy V, Leibach FH. Human placenta: a direct target for cocaine action. Placenta 1994; 15: 785-795.
37. Ganapathy V, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Drug Deliv Rev 1999; 38: 99-110.
38. Gershon MD. Roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999; 13(Suppl 2): 15-30.